Abstract:Fucosylation (Fuc) of glycoproteins plays an important role in regulating protein function and has been associated with the development of several cancer types including prostate cancer (Pca). Therefore, the research of Fuc glycoproteins has attracted increasing attention recently in the analytical field. Herein, a strategy based on lectin affinity enrichments of intact glycopeptides followed by mass spectrometry has been established to evaluate the specificities of various Fuc-binding lectins for glycosite-specific Fuc analysis of nonaggressive (NAG) and aggressive (AG) Pca cell lines. The enrichment specificities of Fuc glycopeptides using lectins (LCA, PSA, AAL, LTL, UEA I, and AOL) and MAX extraction cartridges alone, or in tandem, were evaluated. Our results showed that the use of lectin enrichment significantly increased the ratio of fucosylated, glycopeptides to total glycopeptides compared to MAX enrichment. Furthermore, tandem use of lectin followed by MAX increased the number of identifications of Fuc glycopeptides compared to using lectin enrichment alone. LCA, PSA, and AOL showed stronger binding capacity than AAL, LTL, and UEA I. Also, LCA and PSA bound specifically to core Fuc, whereas AOL, AAL, and UEA I showed binding to both core Fuc and branch Fuc. The optimized enrichment method with tandem enrichment of LCA followed by MAX (LCA-MAX) was then applied to examine the Fuc glycoproteomes in two NAG and two AG Pca cell lines. In total, 973 intact Fuc glycopeptides were identified and quantified from 252 Fuc proteins by using the tandem-mass-tags (TMT) labeling and nanoliquid chromatography-mass spectrometry (nanoLC-MS/MS) analysis. Further data analysis revealed that 51 Fuc glycopeptides were overexpressed more than 2-fold in AG cell lines compared to NAG cells. The analysis of protein core fucosylation has great potential for aiding our understanding of invasive activity of AG Pca and may lead to the development of diagnostic approaches for AG Pca.

Analysis of Breast Cancer-Associated Glycosphingolipids Using Electrospray Ionization-Linear Ion Trap Quadrupole Mass Spectrometry.

Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.

Cell Surface-Specific N-glycan Profiling in Breast Cancer.

Aberrant fucosylation of glycosphingolipids in human hepatocellular carcinoma tissues.

Single-cell profiling of surface glycosphingolipids opens a new dimension for deconvolution of breast cancer intratumoral heterogeneity and phenotypic plasticity

Comparative analysis of intact glycopeptides from mannose receptor among different breast cancer subtypes using mass spectrometry

Mass spectrometry (LC-MS/MS) site-mapping of N-glycosylated membrane proteins for breast cancer biomarkers.

Elevated level of serum glycoprotein bifucosylation and prognostic value in Chinese breast cancer

A serum glycomics approach to breast cancer biomarkers

Illuminating the dark space of neutral glycosphingolipidome by selective enrichment and profiling at multi-structural levels

Identification of Breast Cancer Through Spectroscopic Analysis of Cell-Membrane Sialic Acid Expression.

Mass Spectrometry (LC–MS/MS) Identified Proteomic Biosignatures of Breast Cancer in Proximal Fluid

Pathophysiological roles and applications of glycosphingolipids in the diagnosis and treatment of cancer diseases

Site-Specific Fucosylation Analysis Identifying Glycoproteins Associated with Aggressive Prostate Cancer Cell Lines Using Tandem Affinity Enrichments of Intact Glycopeptides Followed by Mass Spectrometry

Dual Isotopic Labeling Combined with Fluorous Solid-Phase Extraction for Simultaneous Discovery of Neutral/sialylated N-glycans As Biomarkers for Gastric Cancer.

Small molecules as potential biomarkers of early gastric cancer: A mass spectrometry imaging approach

Glycosaminoglycans and Glycolipids As Potential Biomarkers in Lung Cancer

Expression of Glucosylceramide Synsthasa in Breast Tumour

Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues

Profiling of aberrant sialylated N-glycans in hepatocellular carcinoma by liquid chromatography mass spectrometry

N-glycan structures of target cancer biomarker characterized by two-dimensional gel electrophoresis and mass spectrometry